China Medical & HealthCare Group Limited provided consolidated earnings guidance for the eleven months ended 30 November 2022. For the period, the company group is expected to record a loss attributable to shareholders of the Company ("Net Loss") for the eleven months ended 30 November 2022 which represents (a) an approximately 26% decrease as compared with the Net Loss for the corresponding period in 2021; (b) an approximately 30% to 50% decrease when compared with the Net Loss for the year ended 31 December 2021; but (c) an approximately 20% to 40% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 HKD | 0.00% | 0.00% | -15.00% |
1st Jan change | Capi. | |
---|---|---|
-15.00% | 94.34M | |
-17.07% | 16.21B | |
+3.60% | 12.44B | |
+5.64% | 11.58B | |
+4.63% | 10.79B | |
+25.48% | 8.26B | |
-0.21% | 7.68B | |
+22.18% | 7.06B | |
+5.00% | 6.67B | |
+52.00% | 4.66B |
- Stock Market
- Equities
- 383 Stock
- News China Medical & HealthCare Group Limited
- China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022